These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30607331)

  • 1. The Impact of CRISPR-Cas System on Antiviral Therapy.
    Bayat H; Naderi F; Khan AH; Memarnejadian A; Rahimpour A
    Adv Pharm Bull; 2018 Nov; 8(4):591-597. PubMed ID: 30607331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs.
    Bayat H; Omidi M; Rajabibazl M; Sabri S; Rahimpour A
    J Microbiol Biotechnol; 2017 Feb; 27(2):207-218. PubMed ID: 27840399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
    Yin LJ; Hu SQ; Guo F
    Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of CRISPR/Cas9 mediated genome editing in farm animals].
    Xing YY; Yang Q; Ren J
    Yi Chuan; 2016 Mar; 38(3):217-26. PubMed ID: 27001476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The new generation tool for CRISPR genome editing: CRISPR/Cpf1].
    Yang F; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):361-371. PubMed ID: 28941336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
    Han Y; Li QW
    Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
    Kennedy EM; Cullen BR
    Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas: biology, mechanisms and relevance.
    Hille F; Charpentier E
    Philos Trans R Soc Lond B Biol Sci; 2016 Nov; 371(1707):. PubMed ID: 27672148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.
    Koujah L; Shukla D; Naqvi AR
    Semin Cell Dev Biol; 2019 Dec; 96():53-64. PubMed ID: 30953741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
    Liu C; Zhang L; Liu H; Cheng K
    J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRISPR-Cas system - from bacterial immunity to genome engineering.
    Czarnek M; Bereta J
    Postepy Hig Med Dosw (Online); 2016 Sep; 70(0):901-16. PubMed ID: 27594566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic applications of CRISPR RNA-guided genome editing.
    Koo T; Kim JS
    Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.
    Li L; Hu S; Chen X
    Biomaterials; 2018 Jul; 171():207-218. PubMed ID: 29704747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CRISPR-Cas system for plant genome editing: advances and opportunities.
    Kumar V; Jain M
    J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of CRISPR/Cas9 mediated virus resistance in agriculturally important crops.
    Khatodia S; Bhatotia K; Tuteja N
    Bioengineered; 2017 May; 8(3):274-279. PubMed ID: 28581909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
    Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
    J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress and applications of gene editing technology CRISPR/Cas in zebrafish].
    Ouyang J; Xue S; Zhou Q; Cui H
    Sheng Wu Gong Cheng Xue Bao; 2020 Jan; 36(1):1-12. PubMed ID: 32072776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.